JOURNAL ARTICLE
[Proceedings could be dangerous! An endocarditis clinical case].
Acta Médica Portuguesa 2007 January
INTRODUCTION: The authors describe a clinical case of infective endocarditis after a transrectal proceeding. Following that some questions were made: Which are the updated guidelines? Which are the risk proceedings?
THE CASE: A 55-year-old man, with aortic/pulmonary vavuloplasties and haemorrhoids developed an infectious endocarditis, by Streptococcus Viridans, after a rigid proctosigmoidoscopy. Following the endocarditis the patient suffered a pleuritis and pneumonia, those health problems justified 7 months in hospital.
DISCUSSION: The case was a co-guiltiness clinical problem which needs a multidisciplinary discussion (cardiologists, general practioners and physicians whose make invasive proceedings). The International Guidelines, with C level of evidence, omitted some potential invasive examinations and treatments so those need to be clarified. In patients with Infective Endocarditis high risk, who had haemorrhoids, before transrectal proceedings antibiotic prophylaxis may be considered.
THE CASE: A 55-year-old man, with aortic/pulmonary vavuloplasties and haemorrhoids developed an infectious endocarditis, by Streptococcus Viridans, after a rigid proctosigmoidoscopy. Following the endocarditis the patient suffered a pleuritis and pneumonia, those health problems justified 7 months in hospital.
DISCUSSION: The case was a co-guiltiness clinical problem which needs a multidisciplinary discussion (cardiologists, general practioners and physicians whose make invasive proceedings). The International Guidelines, with C level of evidence, omitted some potential invasive examinations and treatments so those need to be clarified. In patients with Infective Endocarditis high risk, who had haemorrhoids, before transrectal proceedings antibiotic prophylaxis may be considered.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app